Neuroimmunology
Autoantibodies: mechanism and testing
Dec. 20, 2024
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Melkersson-Rosenthal syndrome …
- Updated 05.14.2024
- Released 04.20.2004
- Expires For CME 05.14.2027
Melkersson-Rosenthal syndrome
Introduction
Overview
Recurrent facial palsy with orofacial swelling and fissuring of the tongue is known as Melkersson-Rosenthal syndrome. This article provides a review of the clinical features, hypothesized pathophysiology, and management of this syndrome.
Key points
|
• Melkersson-Rosenthal syndrome should be suspected in cases of recurrent facial palsy associated with swelling of orofacial structures or a furrowed tongue. | |
|
• Biopsy of suggestive lesions typically reveals noncaseating granulomas with perivascular and lymphatic inflammatory cell infiltration. | |
|
• The pathophysiology involves an immunologically mediated inflammatory response. | |
|
• Treatment consists of various immune-suppressing and modulating agents, along with surgical correction of disfiguring lesions as necessary. |
Historical note and terminology
In 1928, Ernst Melkersson (1883-1930), a Swedish physician, described a 35-year-old woman with facial edema and paralysis (56). Shortly after, in 1931, Curt Rosenthal (1892-1937), a German neurologist, described three patients who had fissured or plicated tongues in addition to orofacial swelling and facial palsies, and he also proposed a link between the triad of symptoms. Subsequently, the triad of clinical findings came to be known as the Melkersson-Rosenthal syndrome (69).
When the characteristic facial swelling is confined to the lips and occurs in a monosymptomatic or oligosymptomatic form (ie, in isolation or in conjunction with either a furrowed tongue or facial palsy), it is referred to as Miescher cheilitis or cheilitis granulomatosa (34; 74). If granulomatous swelling is localized mainly to the eyelids, the disorder is referred to as granulomatous blepharitis and considered a monosymptomatic form of the Melkersson-Rosenthal syndrome (95).
Clinical manifestations
Presentation and course
|
• Melkersson-Rosenthal syndrome is characterized by the triad of recurrent facial palsy, orofacial swelling, and a furrowed tongue (lingua plicata). | |
|
• The full triad of symptoms is uncommon, making the correct diagnosis of Melkersson-Rosenthal syndrome difficult at times. | |
|
• Orofacial swelling is the most consistent and dominant feature of the Melkersson-Rosenthal syndrome. | |
|
• The facial palsy is manifested as a peripheral VIIth nerve dysfunction, clinically identical to that of Bell palsy. | |
|
• Melkersson-Rosenthal syndrome may also present with dysfunction of other cranial nerves, such as the vagus and glossopharyngeal nerves. |
Melkersson-Rosenthal syndrome is characterized by the triad of recurrent facial palsy, orofacial swelling, and a furrowed tongue (lingua plicata). The full triad of symptoms is uncommon and present in only 8% to 25% of patients, making the correct diagnosis difficult at times (34; 23; 09; 53; 28; 05). If only one or two components of the triad are present, the disorder is considered, respectively, a monosymptomatic or oligosymptomatic form of the Melkersson-Rosenthal syndrome (26).
In Hornstein’s series of 73 patients and in Greene and Rogers’ series of 36 patients, 18% and 28%, respectively, were recognized as having monosymptomatic lip swelling (ie, cheilitis granulomatosa or orofacial granulomatosis) (34; 86; 39; 76; 87). In El-Hakim and Camacho-Alonso’s combined series of 11 patients, eight manifested only cheilitis granulomatosa (12; 22). And in Greene and Rogers’ series of 36 patients, half of them had oligosymptomatic Melkersson-Rosenthal syndrome (34).
Orofacial granulomatosis manifests clinically as painless labial enlargement, perioral and mucosal edema, oral ulcers, and gingivitis (87); it is characterized pathologically by non-necrotizing granulomatous inflammation of the oral and maxillofacial region. When the swelling only affects the lips, the pathology is called Miescher granulomatous cheilitis.
Orofacial swelling is the most consistent and dominant feature of the Melkersson-Rosenthal syndrome (53). It is a localized, painless, nonpruritic, and nonpitting form of lymphedema (14). Unlike true angioedema, the facial swelling in Melkersson-Rosenthal syndrome often develops gradually (98). In a review of 200 patients diagnosed with Melkersson-Rosenthal syndrome, orofacial swelling was the most frequent initial presenting sign (100). The lips are most commonly affected, with the swelling sometimes confined only to the lips. The upper lips are involved more frequently than the bottom lips. The swelling can be asymmetric or unilateral and is usually nontender, but it can be associated with pain or erythema; it may also involve various intraoral structures such as the gingiva, palate, tongue, pharynx, and larynx (34; 100). During the first few episodes, the facial swelling is usually short-lived, but with repeated episodes, the swelling may fail to clear, with residual swelling becoming firm and indurated with granulomatous inflammation (68). Less commonly, the swelling can involve the eyelid and orbital tissues, presenting as a granulomatous blepharitis (57; 75; 16; 48; 66). In some cases, the orofacial swelling can become prominent, causing significant cosmetic disfigurement.
The facial palsy is manifested as a peripheral VIIth nerve dysfunction, clinically identical to that of Bell palsy. It was one of the initial symptoms in 31% of patients diagnosed with the Melkersson-Rosenthal syndrome in a review of 117 patients reported in the literature between 1965 and 1990 (100). In another series of 36 patients with the Melkersson-Rosenthal syndrome, a comparable 39% reported developing a facial paresis as the initial presenting symptom (34). The facial palsy can vary in severity from mild to complete and is typically recurrent and unilateral but can be bilateral or alternating. Some two thirds who initially present with unilateral facial paresis subsequently develop alternating facial paresis (metachronous contralateral paresis), whereas only about 5% have simultaneous facial diparesis (67). Episodes of facial palsy usually come on acutely and typically last from days to months. Initial episodes are normally short-lived, but with repeated episodes, the duration of facial paresis typically becomes prolonged or permanent. The facial paralysis usually occurs concomitantly on the side of facial swelling but may occur months to years before or after the onset of orofacial swelling (100; 68; 75).
In addition to its hallmark facial nerve involvement, there have been a few case reports of Melkersson-Rosenthal syndrome presenting with dysfunction of other cranial nerves, such as the vagus and glossopharyngeal nerves (47), the auditory nerve (77), or the occulomotor nerve (04; 61). Such presentations are rare.
The fissured tongue is present in 30% to 77% of patients with Melkersson-Rosenthal syndrome (90). In a review of 42 patients, it was present in about 50% (100), and it was present in 47% in another series of 72 patients (23). Characteristically, there may be one or many longitudinal furrows with smaller fissures that radiate out laterally, giving rise to the appearance of a “plicated” or “scrotal tongue.” The fissuring on the tongue is usually congenital and completely asymptomatic in most patients. Rarely, the deep furrows have been associated with local bacterial and fungal colonization and overgrowth but are otherwise an asymptomatic finding. Many authors have reported the presence of plicated tongues among relatives (34; 68; 03), suggesting a possible genetic etiology. However, the vast majority of patients have no family history of the disorder, and its presence in more than one family member may merely reflect a fairly common baseline prevalence of approximately 5% in the general population (36).
Acute respiratory distress syndrome may occur in some cases and is characterized by acute diffuse, inflammatory lung injury, which causes increased alveolar-capillary permeability and loss of aerated lung tissue (49).
Prognosis and complications
Melkersson-Rosenthal syndrome prognosis is variable. Most patients experience a chronic relapsing-remitting course of orofacial swelling and facial paralysis, often separated by months to years, but some may experience persistent, progressive, or permanent symptoms with each successive episode (68). The interventional use of various steroids and antibiotics is anecdotally reported to improve outcomes with longer periods of symptomatic remission (11).
Compared with recurrent Bell palsy, the prognosis for recovery with recurrent facial paresis in Melkersson-Rosenthal syndrome is much worse; in patients with recurrent facial palsy, only 14% of patients with Melkersson-Rosenthal syndrome recover to House-Brackmann grade 1 by 1 year when compared to 71% of patients with recurrent Bell palsy (91).
Complications from Melkersson-Rosenthal syndrome-associated facial palsy parallel those from typical Bell palsy. In the acute phase of facial nerve paralysis, the inability to properly close and lubricate the affected eyelid can give rise to corneal and scleral injury. In addition, reinnervation of the facial nerve fibers may be incomplete or aberrant, leading to variable outcomes of sensory, motor, or parasympathetic nerve fiber deficits.
In addition, there may be associated anxiety, depression, and suicidal ideation as a consequence of often persisting disfigurement (43).
Clinical vignette
Case 1. Melkersson-Rosenthal syndrome (40). A 38-year-old woman with other medical issues had a history of recurrent alternating facial nerve paresis, with episodes at ages 5, 18, 30, and 32. Following bilateral facial palsy, she was unable to smile and had a relatively smooth left nasolabial furrow. She also had lingua plicata (fissured tongue), as did her 14-year-old daughter. MRI of the head, CSF studies, and basic laboratory tests were normal.
Case 2. Melkersson-Rosenthal syndrome (05). A 38-year-old woman was diagnosed with Melkersson-Rosenthal syndrome based on its three clinical features: recurrent facial palsy, orofacial swelling, and fissured tongue. A corticosteroid (1 mg/kg/day of oral prednisolone) was prescribed for a week and then tapered off over 2 weeks by gradually lowering the dose.
-
Lower lip swelling and left hemifacial palsy in Melkersson-Rosenthal syndrome
Photograph shows swelling of the lower lip in a 38-year-old woman referred by her dentist for evaluation of recurrent swelling of the lower lip along with left hemifacial palsy. She was diagnosed with Melkersson-Rosenthal syndr...
Case 3. Granulomatous cheilitis of Miescher (87). A 27-year-old woman presented with a 3-month history of persistent upper lip swelling. Microscopy of a biopsy from the upper lip revealed the following: (1) the epidermis exhibited parakeratotic stratified squamous epithelium, variable acanthosis, mild spongiosis, irregular rete ridges, and lymphocytic exocytosis; (2) mild to moderate dermal edema and the presence of a noncaseating granuloma comprising epithelioid cells, with some lymphocytes, histocytes, multinucleated giant cells, and occasional plasma cells; (3) a few dilated lymphatics were present adjacent to the granuloma, along with mild perivascular lymphoplasmacytic cuffing. A diagnosis of granulomatous cheilitis was made. She was treated with intralesional triamcinolone acetonide (10 mg/ml) over four sittings with a 3-week interval between each sitting. There was a nearly 40% reduction in the lesion over 3 months of follow-up.
-
Swollen and firm upper lip and perioral area in granulomatous cheilitis of Miescher
Non-tender diffuse swollen and firm upper lip and perioral area with areas of scaling in a 27-year-old woman who presented with a 3-month history of this problem. Biopsy from the lesion was consistent with granulomatous cheilit...
Biological basis
|
• The etiology of Melkersson-Rosenthal syndrome is unknown. |
Etiology and pathogenesis
The etiology is unknown. There have been many proposed theories, including possible genetic, allergic, autoimmune, and infectious etiologies (07; 97). However, none have unequivocally been shown to be causative (34; 68; 88; 18).
Some controversy exists regarding the uncanny similarities present in the clinical and histopathologic manifestations of the oral pathology between Melkersson-Rosenthal syndrome and Crohn disease. Some consider macrocheilitis (cheilitis granulomatosa; granulomatous cheilitis), a granulomatous affliction of the mouth and an oligosymptomatic manifestation of the Melkersson-Rosenthal syndrome, to represent a regional manifestation of Crohn disease (55; 74). This is substantiated by reports of a few patients who were initially diagnosed with granulomatous cheilitis but were subsequently also diagnosed with Crohn disease (74; 85). Interestingly, in a series of 72 patients evaluated at the Mayo Clinic in Rochester, Minnesota, over a period of 30 years, about 8% of patients were also diagnosed as having Crohn disease as a comorbidity (23). However, as most patients who develop the Melkersson-Rosenthal syndrome do not have manifestations of Crohn disease, this is a point of continued controversy. In a 30-year follow-up study of patients with Melkersson-Rosenthal syndrome, none with the full syndrome developed Crohn disease, but two developed ulcerative colitis (35).
An immune-mediated inflammatory reaction appears to be central to the development of the orofacial symptoms. This is supported by the fact that many successful treatments for this disorder are immune-suppressing agents (see Management). There have also been reports of various autoimmune-mediated diseases, such as multiple sclerosis (10), Hashimoto thyroiditis (73; 18; 52), Crohn disease (72; 29), and mixed connective tissue disease (40), occurring in association with Melkersson Rosenthal syndrome.
Early during the inflammatory process, mild epithelial hyperplasia is characterized by dilated lymphatics, with perivascular congregations of histiocytes, lymphocytes, and plasma cells in a background of nonspecific edema. As the lesions become established over weeks of persistent swelling, biopsy often reveals areas of noncaseating granulomas with perivascular lymphocytic infiltration in the lamina propria or dermal layers (34; 31; 100; 68; 48; 66). Noncaseating intralymphatic granulomas have also been visualized and are postulated to cause lymphatic obstruction and associated facial tissue edema (32). Similar pathologic findings of lymphatic flow obstruction were demonstrated with abnormal lymphoscintigraphy studies in three of four patients diagnosed with Melkersson-Rosenthal syndrome (59).
Postulated mechanisms for the disorder include reactive immune-mediated responses directed toward some nonspecific offending stimulus that result in autonomic vasomotor disturbances of the vasa nervorum and small penetrating arterioles of the facial nerve and subcutaneous tissue. Those processes are subsequently postulated to allow for greater vascular permeability, antigenic penetration, and tissue reactivity, followed by the characteristic granulomatous changes (79; 37).
Serum IgG levels were elevated in five patients with Melkersson-Rosenthal syndrome (96). Two of the five patients also demonstrated elevated CSF IgG and albumin levels, but none demonstrated increased IgG indexes or oligoclonal bands in the CSF. Yetiser and colleagues argued that these findings support the idea that there is a sustained immunologic response from an as yet unidentified stimulus in patients with recurrent facial palsies and Melkersson-Rosenthal syndrome (96).
Kaminagakura and Jorge reported more T and B cells within and surrounding granulomatous lesions in a patient manifesting the complete triad of symptoms, compared to primarily T cells with very few B cells in the biopsy of a patient with the monosymptomatic form (42). They suspect different and greater humorally mediated host responses for the more complete form of disease presentation.
A 52-year-old woman with Melkersson-Rosenthal syndrome in conjunction with isolated IgE hypogammaglobulinemia has been reported (58). From this case, the authors concluded that an IgE-mediated hypersensitivity reaction is unlikely to account for the development of the Melkersson-Rosenthal syndrome.
Presumably, the underlying mechanism for the facial palsy in Melkersson-Rosenthal syndrome is related to increased tissue swelling in the facial nerve sheath; thus, decompression of the facial nerve in its intratemporal course may prevent recurrent episodes of nerve compression within a tight and unyielding bony canal. During decompression of the facial nerve intraoperatively in a patient with the Melkersson-Rosenthal syndrome, Dutt and colleagues described a pathological “large oedematosus facial nerve sheath,” providing some support for this purported pathophysiology of facial palsy (21).
A genetic predisposition involving associated and protective genes is suspected (29). In a case-control study of 36 patients with Melkersson-Rosenthal syndrome and 297 controls, there was a significant increase in the expression of HLA A*02, HLA DRB1*11, and HLA DQB1*03, and low levels of HLA A*01, HLA DRB1*04, HLA DRB1*07, and HLA DQB1*02 in patients with Melkersson-Rosenthal syndrome as compared with the control group (29).
In a Chinese Han family with Melkersson-Rosenthal syndrome, Xu and colleagues identified a mutation in the FATP1 gene, although the clinical significance of this finding is not yet clear (94). The gene codes for fatty acid transport protein 1 (FATP1), an insulin-sensitive fatty acid transporter involved in diet-induced obesity. After this report, no pathologic mutations in the FATP1 gene were identified in 14 unrelated individuals with Melkersson-Rosenthal syndrome (64).
Epidemiology
|
• Melkersson-Rosenthal syndrome is rare. | |
|
• The symptoms of Melkersson-Rosenthal syndrome usually occur during the second decade but have been reported to affect patients across nearly the entire age span. |
The disorder is rare, and the true incidence is not clearly known. The symptoms of Melkersson-Rosenthal syndrome usually occur during the second decade but have been reported to affect patients across a wide range of ages from 2 to 81 years (34; 100; 75; 63). In a series of 36 patients reviewed by Greene and Rogers, the mean age of initial symptom onset was 33 years. Another systematic review, pooling data from published cases, suggested that females are more often affected than males (56% vs. 44%) (100).
There are several reports of patients with Melkersson-Rosenthal syndrome who have family members with components of the triad of symptoms, but the complete triad is rarely reported. In a review of 27 patients, three patients had first-degree relatives who had plicated tongues, and only one patient reported all three symptoms in a family member (ie, a sister), but this was not substantiated by the authors (11). Another series of 42 patients studied at the Mayo Clinic revealed no family history for the complete triad of symptoms, but two patients had three family members with plicated tongues, two patients had three family members who had Bell palsy, and another two patients had four family members with orofacial swelling (100). In another series of 15 patients, family history was positive in 5 of 16 patients (31%) with facial paresis in Melkersson-Rosenthal syndrome (80). The significance of such findings remains unclear but may possibly suggest a familial predisposition.
Prevention
There is no known prevention of the disease itself, but early detection is important to prevent cosmetic disfigurement. The facial swelling in Melkersson-Rosenthal syndrome may cause permanent swelling with cosmetic disfigurement from multiple relapses, which can be prevented by early detection and timely initiation of treatment (98).
Differential diagnosis
Confusing conditions
The differential diagnosis of Melkersson-Rosenthal syndrome includes a variety of disorders that can mimic the histopathologic and clinical findings (100; 68; 11).
Melkersson-Rosenthal syndrome has been repeatedly misdiagnosed as recurrent Bell palsy (98). The differential diagnosis for disorders that can produce peripheral facial nerve palsies include Bell palsy, skull trauma, Ramsay Hunt syndrome, herpes simplex virus 1, HIV, Lyme disease, sarcoidosis, tuberculosis, syphilis, vasculitis, acute demyelinating neuropathies, and neoplastic lesions.
Entities that can cause orofacial swelling and granulomatosis include facial trauma, insect bites, cellulitis, lymphatic obstruction, eyelid lymphedema, eosinophilic facial swelling, angioedema, periodontal and skull-based infections, silica-induced granulomatous cheilitis, contact dermatitis, acute leukemia, leprosy, syphilis, tuberculosis, sarcoidosis, and Crohn disease.
In a patient with upper facial swelling, an absence of orolabial swelling, and lack of facial neuropathy, a diagnosis of Morbihan disease is preferred over Melkersson-Rosenthal syndrome, especially if the patient has a history of rosacea (51). Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It may be a complication of rosacea and may occur at any stage of that disease.
Diagnostic workup
|
• Diagnosis depends on clinicopathologic correlation. | |
|
• Biopsy of the swollen orofacial tissue should be sought to document the presence of noncaseating epithelioid-cell granulomas. | |
|
• Routine examination of tissue for mycobacterial infection (with Ziehl-Neelsen staining) and foreign bodies should also be performed because these entities may produce characteristic granulomatous changes. |
Because there are no pathognomonic laboratory findings for the Melkersson-Rosenthal syndrome, diagnosis depends on clinicopathologic correlation (93). Thus, considering all the entities in the differential diagnosis by clinical findings, laboratory tests, imaging studies, and histology is essential to correctly establish the diagnosis. Sometimes, the correct diagnosis may only be reached based on excluding other causes of orofacial granulomatosis (68).
Biopsy of the swollen orofacial tissue should be sought to document the presence of noncaseating epithelioid-cell granulomas (09; 30). The most common biopsy site is the upper lip, followed by the lower lip, gingiva, and palate (30). Clinical and histopathological analysis of rare gingival or palatal lesions is important as all histopathological findings of the disease have been detected in these sites. In the initial phase, there is a lymphoplasmacytic inflammatory infiltrate, followed by a granulomatous infiltrate, and subsequently, fibrosis. The most important and specific finding is the presence of ill-defined and well-formed granulomas. In rare cases, swelling and noncaseating epithelioid-cell granulomas may involve the genitalia (15). However, typical granulomas may be absent on biopsy, but this should not exclude the diagnosis of Melkersson-Rosenthal syndrome in the presence of typical symptoms, as individual granulomas reportedly form and resolve within days to weeks and do not necessarily parallel the clinical course of swelling (37; 30). Lymphoplasmacytic inflammatory infiltrate can be seen in early and late stages (30). Edema, fibrosis, vasodilatation, and congestion are the most common findings in the lamina propria. Often, the biopsy may only reveal nonspecific inflammatory changes or fibrosis (34; 100; 68). Routine examination of tissue for mycobacterial infection (with Ziehl-Neelsen staining) and foreign bodies should also be performed because these entities may produce characteristic granulomatous changes.
Other laboratory studies may be useful depending on the index of clinical suspicion and include serum angiotensin-converting enzyme levels, gallium scan, chest x-ray, and purified protein derivative placement to rule out sarcoidosis and tuberculosis. HIV, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus-1 viral titers, serum Lyme titers, and venereal disease research laboratory test (VDRL) may be useful to exclude infections. CSF cell count, protein, and cytology examination to check for the presence of acute inflammatory demyelinating polyradiculoneuropathy, multiple sclerosis, meningeal carcinomatosis, and various meningitides should also be considered in the diagnostic workup.
Panorex periodontal films and skull CT may be indicated to evaluate for local infection and abscesses. For recurrent facial paresis, especially when associated with a progressive course and accompanied by other cranial nerve dysfunction, an MRI of the brain with gadolinium contrast may be useful to exclude mass or infiltrating lesions involving the facial nerve.
If oral lesions associated with cobblestoning or skin tags accompanied by characteristic gastrointestinal complaints are present, a referral to the gastrointestinal specialist for endoscopy may be indicated to exclude Crohn disease.
Management
|
• The treatment for Melkersson-Rosenthal syndrome is primarily aimed at reducing the orofacial swelling and inflammation of the facial nerve and preventing recurrences. | |
|
• Effective treatments include systemic or intralesional corticosteroids, antibiotics, nonsteroidal anti-inflammatories, cosmetic surgery, and more recently, monoclonal antibodies. |
The treatment for Melkersson-Rosenthal syndrome is primarily aimed at reducing the orofacial swelling and inflammation of the facial nerve and preventing recurrences. Effective treatments include systemic or intralesional corticosteroids, antibiotics, nonsteroidal anti-inflammatories, cosmetic surgery, and more recently, monoclonal antibodies.
In addition, patients require emotional support and may need additional treatment for anxiety, depression, and suicidal ideation (43).
Corticosteroids are an effective therapy (100; 54; 20), although not all cases respond (71). Topical steroids have been used for mild cases of orofacial swelling with fair results (89). Intralesional corticosteroid (triamcinolone) injections are commonly used and may decrease facial swelling in more severe cases, often for prolonged periods of remission (31; 100; 78; 11; 89; 57; 75; 22; 65; 16; 20). Intravenous or oral methylprednisolone has also been associated with temporary improvements in orofacial swelling and facial paresis in several patients (46; 31; 03; 99; 57). Following steroid treatment, symptoms may improve or remit for weeks to months but may also recur, necessitating maintenance therapy or repeated high-dose bolus administrations. Early treatment of facial swelling with steroids is advocated because the longer the delay in treatment, the less effective and incomplete the recovery (57).
Antibiotics such as tetracycline, clofazimine, dapsone, metronidazole, and minocycline have also been used empirically, not only for their antibactericidal qualities but also for their reported properties in preventing the formation of granulomas (44; 25; 20; 13; 70). In one series, the antileprosy drug clofazimine was used as sole therapy in 18 patients and decreased the frequency and intensity of facial edema in 94%; however, only 62% of these patients were relapse-free during a follow-up period of up to 3 years (84). Antibiotics are commonly used in combination with steroids and provide better clinical outcomes than either therapy alone (27; 11; 20). However, antibiotics have sometimes been used in lieu of steroids as a first-line approach to avoid the negative effects of systemic corticosteroids (70). Clofazimine, in conjunction with systemic or intralesional corticosteroids, produced satisfactory results in three patients with Miescher cheilitis (12). The combination of minocycline (tetracycline derivative) and prednisone produced favorable results with cessation of disease progression in two children who were 10 and 12 years of age; however, one patient required continued maintenance doses of minocycline with occasional intralesional steroid injections (78). Another treatment option for orofacial edema includes intralesional betamethasone combined with oral doxycycline (20). The antiparasitic drug hydroxychloroquine has also been used empirically for its immunosuppressant and anti-inflammatory properties (92).
Tranilast (N-[3,4-demethoxycinnamoyl]-anthranilic acid) is an oral cytokine inhibitor and mast cell membrane stabilizer, which has been reported to improve swelling of the eyelid in granulomatous blepharitis, a likely monosymptomatic variant of Melkersson-Rosenthal syndrome (45; 38).
5-fluorouracil has been tried with anecdotal benefit (02).
Infliximab is a chimeric, monoclonal antibody that binds soluble bioactive tumor necrosis factor alpha and neutralizes its proinflammatory properties. An overproduction of tumor necrosis factor alpha contributes to the inflammatory mucosal and dermal damage in Melkersson-Rosenthal syndrome. Infliximab dramatically reduced lip swelling in a 24-year-old woman with granulomatous cheilitis resistant to initial treatments with minocycline, erythromycin, and oral prednisolone (08). Infliximab at 3 mg/kg administered at 0, 2, 6, and 9 weeks resulted in noticeable reduction in the swelling as early as the second infusion. The maintenance dose was increased to infusions of 5 mg/kg every 8 weeks, and the patient remained stable with restored anatomy of her lips. Another patient presenting with granulomatous blepharitis was successfully treated with infliximab until she developed side effects, at which time she was switched over to adalimumab (another monoclonal antibody directed against tumor necrosis factor alpha) with a good clinical response (41). Other patients with typical or atypical forms of Melkersson-Rosenthal syndrome have achieved total remission with adalimumab (77; 19).
Various treatment modalities have been employed in granulomatous cheilitis (eg, glucocorticoids, antibiotics, immunomodulatory and biological agents, surgical debulking, and laser therapy), but no treatment modality has been shown to be predictably successful (62; 76; 87). Intralesional corticosteroid therapy has been used more frequently, either alone or in combination with other modalities (62; 76; 87). Granulomatous cheilitis is refractory to treatment with methotrexate (81).
For disfiguring swelling resistant to usual medical treatment, surgical resection of swollen tissue from the affected lips (chiloplasty) and eyelids (blepharoplasty) has been advocated. These surgical procedures may provide helpful restorative cosmetic outcomes (100; 24; 11; 50; 82; 06), but not uncommonly, even after surgery, orofacial swelling may recur, necessitating repeat surgical procedures (60). Cheiloplasty in combination with intradermal steroids (triamcinolone) and postoperative tetracycline may provide superior outcomes with longer periods of remission than surgery alone (11). Some authors recommend surgery only after a stable, relapse-free period of 8 to 12 months to avoid stimulation and aggravation of the granulomatous inflammatory process by the surgical procedure itself (50).
For recurrent or intractable facial palsies, some authors have recommended complete surgical decompression of the facial nerve (33; 21; 17; 83; 01). Dutt and colleagues reported diminished frequency and severity of facial palsies following middle fossa decompression of the facial nerve in a 27-year-old woman with Melkersson-Rosenthal and recurrent facial palsies (21). Complete cessation of recurrent facial palsy for more than 8 years despite recurrent facial edema has also been reported in a patient with Melkersson-Rosenthal syndrome after facial nerve decompression (33).
As the usual course of facial palsy in Melkersson-Rosenthal syndrome is one characterized by spontaneous remissions and relapses (34; 31; 100; 68), published reports of improvement in function after a particular interventional treatment should be carefully scrutinized with the natural course of the symptom in mind.
Media
References
- 01
- Alencar TN, Botelho MM, Carasek N, Bahmad Jr F. Surgical treatment outcome for familial Melkersson-Rosenthal syndrome. Am J Case Rep 2023;24:e938670. PMID 36755481
- 02
- Alessi DM, Azhdam AM, Borrelli M. A case of Melkersson-Rosenthal syndrome treated with 5-FU. Ear Nose Throat J 2021;100(6_suppl):873S-5S. PMID 34448401
- 03
- Alioglu Z, Caylan R, Adanir M, Ozmenoglu M. Melkersson-Rosenthal syndrome: report of three cases. Neurol Sci 2000;21(1):57-60. PMID 10938204
- 04
- Aluclu MU, Keklikci U, Guzel A, Unlu K, Tatli M. Melkersson-Rosenthal syndrome with partial oculomotor nerve palsy. Ann Saudi Med 2008;28(2):135-7. PMID 18398275
- 05
- Aoun G, Skandri N, Ghattas H, Maksoud C. Melkersson-Rosenthal syndrome in a 38-year-old female patient: a rare case with complete triad. Cureus 2022;14(7):e27427. PMID 36051736
- 06
- Azimi R, Lee L, Stams VE. Surgical debulking of persistent orofacial swelling in a patient with Melkersson-Rosenthal syndrome. Plast Reconstr Surg Glob Open 2021;9(11):e3930. PMID 35028261
- 07
- Azzara A, Cassano I, Lintas C, et al. Melkersson-Rosenthal syndrome and migraine: a new phenotype associated with SCN1A variants? Genes (Basel) 2023;14(7):1482. PMID 37510386
- 08
- Barry O, Barry J, Langan S, Murphy M, Fitzgibbon J, Lyons JF. Treatment of granulomatous cheilitis with infliximab. Arch Dermatol 2005;141(9):1080-2. PMID 16172303
- 09
- Bohra S, Kariya PB, Bargale SD, Kiran S. Clinicopathological significance of Melkersson-Rosenthal syndrome. BMJ Case Rep 2015;2015. PMID 26231188
- 10
- Cabrera-Gomez JA, Echazabal-Santana N, Real-González Y, et al. Hereditary Melkersson-Rosenthal syndrome and multiple sclerosis. Mult Scler 2005;11(3):364-6. PMID 15957522
- 11
- Camacho F, Garcia-Bravo B, Carrizosa A. Treatment of Miescher’s cheilitis granulomatosa in Melkersson-Rosenthal syndrome. J Eur Acad Dermatol Venereol 2001;15(6):546-9. PMID 11843214
- 12
- Camacho-Alonso F, Bermejo-Fenoll A, Lopez-Jornet P. Mieschers cheilits granulomatosa. A presentation of five cases. Med Oral Patol Oral Cir Bucal 2004;9:425-9. PMID 15580120
- 13
- Casper J, Mohammad-Khani S, Schmidt JJ, et al. Melkersson-Rosenthal syndrome in the context of sarcoidosis: a case report. J Med Case Rep 2021;15(1):488. PMID 34602094
- 14
- Chen X, Jakobiec FA, Yadav P, Werdich XQ, Fay A. Melkersson-Rosenthal syndrome with isolated unilateral eyelid edema: an immunopathologic study. Ophthal Plast Reconstr Surg 2015;31(3):e70-7. PMID 24853119
- 15
- Chu Z, Liu Y, Zhang H, Zeng W, Geng S. Melkersson-Rosenthal syndrome with genitalia involved in a 12-year-old boy. Ann Dermatol 2016;28(2):232-6. PMID 27081272
- 16
- Cocuroccia B, Gubinelli E, Annessi G, Zambruno G, Girolomoni G. Persistent unilateral orbital and eyelid oedema as a manifestation of Melkersson-Rosenthal syndrome. J Eur Acad Dermatol Venereol 2005;19(1):107-11. PMID 15649204
- 17
- Dai C, Li J, Yang S, et al. Subtotal facial nerve decompression for recurrent facial palsy in Melkersson Rosenthal syndrome. Acta Otolaryngol 2014;134(4):425-8. PMID 24512460
- 18
- D’Amore M, Lisi S, Sisto M, Cucci L, Dow T. Molecular identification of Myocbacterium avium subspecies paratuberculosis in an Italian patient with Hashimoto’s thyroiditis and Melkersson-Rosenthal syndrome. J Med Microbiol 2010;59(Pt 1):137-9. PMID 19797462
- 19
- de Moll EH, Lebwohl MG. Melkersson-Rosenthal syndrome successfully treated with adalimumab. Cutis 2018;101(2):122-4. PMID 29554155
- 20
- Dhawan SR, Saini AG, Singhi PD. Management strategies of Melkersson-Rosenthal syndrome: a review. Int J Gen Med 2020;13:61-5. PMID 32161488
- 21
- Dutt SN, Mirza S, Irving RM, Donaldson I. Total decompression of facial nerve for Melkersson-Rosenthal syndrome. J Laryngol Otol 2000;114(11):870-3. PMID 11144840
- 22
- El-Hakim M, Chauvin P. Orofacial granulomatosis presenting as persistent lip swelling: review of 6 new cases. J Oral Maxillofac Surg 2004;62(9):1114-7. PMID 15346363
- 23
- Elias MK, Mateen FJ, Weiler CR. The Melkersson-Rosenthal syndrome: a retrospective study of biopsied cases. J Neurol 2013;260(1):138-43. PMID 22836908
- 24
- Ellitsgaard N, Andersson AP, Worsaae N, Medgyesi S. Long-term results after surgical reduction cheiloplasty in patients with Melkersson-Rosenthal syndrome and cheilitis granulomatosa. Ann Plast Surg 1993;31(5):413-20. PMID 8285526
- 25
- Emiroglu N, Su O, Cengiz FP, Onsun N. Successful treatment of Melkersson-Rosenthal syndrome with dapsone: a case report and review of the literature. Dermatol Online J 2016;22(10). PMID 28329598
- 26
- Estacia CT, Gameiro Filho AR, da Silveira IBE, Gameiro RR, Barba ALSD. Melkersson-Rosenthal syndrome: a rare variant of the monosymptomatic form. GMS Ophthalmol Cases 2022;12:Doc04. PMID 35291587
- 27
- Fisher AA. Chronic lip edema with particular reference to the Melkersson-Rosenthal syndrome (MRS). Cutis 1990;45(3):144-6. PMID 2311430
- 28
- Gavioli CF, Florezi GP, Lourenço SV, Nico MM. Clinical profile of Melkersson-Rosenthal syndrome/orofacial granulomatosis: a review of 51 patients. J Cutan Med Surg 2021;25(4):390-6. PMID 33573395
- 29
- Gavioli CFB, Nico MMS, Florezi GP, Lourenço SV. The histopathological spectrum of Melkersson-Rosenthal syndrome: analysis of 47 cases. J Cutan Pathol 2020a;47(11):1010-7. PMID 32578236
- 30
- Gavioli CFB, Nico MMS, Panajotopoulos N, et al. A case-control study of HLA alleles in Brazilian patients with Melkersson-Rosenthal syndrome. Eur J Med Genet 2020b;63(7):103879. PMID 32045706
- 31
- Glickman LT, Gruss JS, Birt BD, Kohli-Dang N. The surgical management of Melkersson-Rosenthal syndrome. Plast Reconstr Surg 1992;89(5):815-21. PMID 1561252
- 32
- Gonzalez-Garcia C, Aguayo-Leiva I, Pian H, Fernandez-Guarino M, Jaen Olasolo P. Intralymphatic granulomas as a pathogenic factor in cheilitis granulomatosa/Melkersson-Rosenthal syndrome: report of a case with immunohistochemical and molecular studies. Am J Dermatopathol 2011;33(6):594-8. PMID 21317610
- 33
- Graham MD, Kartush J. Total facial nerve decompression for recurrent facial paralysis: an update. Otolaryngol Head Neck Surg 1989;101(4):442-4. PMID 2508021
- 34
- Greene RM, Rogers RS 3rd. Melkersson-Rosenthal syndrome: a review of 36 patients. J Am Acad Dermatol 1989;21(6):1263-70. PMID 2584463
- 35
- Haaramo A, Kolho KL, Pitkäranta A, Kanerva M. A 30-year follow-up study of patients with Melkersson-Rosenthal syndrome shows an association to inflammatory bowel disease. Ann Med 2019;51(2):149-55. PMID 30983435
- 36
- Halperin V, Kolas S, Jefferis KR, Huddleston SO, Robinson HB. The occurrence of Fordyce spots, benign migratory glossitis, median rhomboid glossitis, and fissured tongue in 2,478 dental patients. J Oral Surg (Chic) 1953;6(9):1072-7. PMID 13088005
- 37
- Hornstein OP. Melkersson-Rosenthal syndrome: a neuro-muco-cutaneous disease of complex origin. Curr Probl Dermatol 1973;5:117-56. PMID 4595076
- 38
- Iwao F, Sawamura D, Yokota K, Shimizu H. Granulomatous blepharitis successfully treated with tranilast. Brit J Dermatol 2003;149(1):222-4. PMID 12890236
- 39
- Jamil RT, Agrawal M, Gharbi A, Sonthalia S. Cheilitis Granulomatosa. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2022. PMID 29261927
- 40
- Jasinska D, Boczon J. Melkersson-Rosenthal syndrome as an early manifestation of mixed connective tissue disease. Eur J Med Res 2015;20:100. PMID 26698837
- 41
- Kakimoto C, Sparks C, White AA. Melkersson-Rosenthal syndrome: a form of pseudoangioedema. Ann Allergy Asthma Immunol 2007:99(2):185-9. PMID 17718107
- 42
- Kaminagakura E, Jorge J Jr. Melkersson Rosenthal syndrome: a histopathologic mystery and dermatologic challenge. J Cutan Pathol 2011;38(2):241-5. PMID 19843194
- 43
- Kana T, Kawamj A, Shamim Z, Rengarajan H. Melkersson-Rosenthal syndrome: a case report with a bipolar perspective. Cureus 2023;15(3):e35955. PMID 37038569
- 44
- Kano Y, Shiohara T, Yagita A, Nagashima M. Treatment of recalcitrant cheilitis granulomatosa with metronidazole. J Am Acad Dermatol 1992;27(4):629-30. PMID 1401320
- 45
- Kato T, Tagami H. Successful treatment of cheilitis granulomatosa with tranilast. J Dermatol 1986;13(5):402-3. PMID 2434543
- 46
- Kesler A, Vainstein G, Gadoth N. Melkersson-Rosenthal syndrome treated by methylprednisolone. Neurology 1998;51(5):1440-1. PMID 9818875
- 47
- Khandpur S, Malhotra AK, Khanna N. Melkersson-Rosenthal syndrome with diffuse facial swelling and multiple cranial nerve palsies. J Dermatol 2006;33(6):411-4. PMID 16700832
- 48
- Kondratiev S, Heher K, Baker BJ, Laver NV. Melkersson-Rosenthal syndrome presenting as chronic eyelid swelling. Opthalmic Surg Lasers Imaging 2010:1-3. PMID 20337335
- 49
- Kosovali BD, Yavuz A, Yesiler FI, Bayar MK. Melkersson-Rosenthal syndrome: a rare cause of recurrent facial nerve palsy and acute respiratory distress syndrome. Case Rep Neurol Med 2018;2018:1373581. PMID 29984016
- 50
- Kruse-Losler B, Presser D, Metze D, Joos U. Surgical treatment of persistent macrocheilia in patients with Melkersson-Rosenthal syndrome and cheilitis granulomatosa. Arch Dermatol 2005;141:1085-91. PMID 16172304
- 51
- Kuraitis D, Coscarart A, Williams L, Wang A. Morbihan disease: a case report and differentiation from Melkersson-Rosenthal syndrome. Dermatol Online J 2020;26(6). PMID 32815689
- 52
- Lee YJ, Cheon CK, Yeon GM, Kim YM, Nam SO. Melkersson-Rosenthal syndrome with Hashimoto thyroiditis in a 9-year-old girl: an autoimmune disorder. Pediatr Neurol 2014;50(5):503-6. PMID 24656464
- 53
- Lin TY, Chiang CH, Cheng PS. Melkersson-Rosenthal syndrome. J Formos Med Assoc 2016;115(7):583-4. PMID 26375775
- 54
- Liu R, Yu S. Melkersson-Rosenthal syndrome: a review of seven patients. J Clin Neurosci 2013;20(7):993-5. PMID 23664134
- 55
- Lloyd DA, Payton KB, Guenther L, Frydman W. Melkersson-Rosenthal syndrome and Crohn’s disease: one disease or two. Report of a case and discussion of the literature. J Clin Gastroenterol 1994;18(3):213-7. PMID 8034917
- 56
- Melkersson E. Ett fall av recidiverande facialispares i samband med ett angioneurotiskt ödem. Hygiea (Stockholm) 1928;90:737-41.
- 57
- Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L. The multiform and variable patterns of onset of orofacial granulomatosis. J Oral Pathol Med 2003:32(4):200-5. PMID 12653858
- 58
- Nakane T, Hatakeyama K, Nakamura K, Aihara M, Nakazawa S. Melkersson-Rosenthal syndrome with isolated immunoglobulin E hypogammaglobulinaemia. J Int Med Res 2007;35(6):922-5. PMID 18035003
- 59
- Nittner-Marszalska M, Krasnowska M, Solarewicz-Madejek K, Jedrzejuk D, Szuba A. Melkersson-Rosenthal syndrome: lymphoscintigraphy-documented impairment and restoration of facial lymphatic drainage in the coruse of the disease. Lymphology 2010;43(1):34-41. PMID 20552818
- 60
- Oliver DW, Scott MJ. Lip reduction cheiloplasty for Miescher’s granulomatous macrocheilitis (Cheilitis granulomatosa) in childhood. Clin Exp Dermatol 2002;27(2):129-31. PMID 11952705
- 61
- Parr K, Tusa M, Jamison R. Melkersson-Rosenthal syndrome associated with multiple cranial nerve palsies and progressive atrophy of facial and extraocular muscles. J Am Acad Dermatol 2012;66(4 suppl 1):AB57.
- 62
- Pathania YS. Current treatment modalities in granulomatous cheilitis. Int J Dermatol 2022;61(6):755-9. PMID 35174873
- 63
- Pavuluri A, Smith S, Narsinghani U. Rare diagnosis of Melkersson-Rosenthal syndrome in a paediatric patient. BMJ Case Rep 2021;14(6):e238431. PMID 34116987
- 64
- Pei Y, Beaman GM, Mansfield D, Clayton-Smith J, Stewart M, Newman WG. Clinical and genetic heterogeneity in Melkersson-Rosenthal Syndrome. Eur J Med Genet 2019;62(6):103536. PMID 30217753
- 65
- Perez-Calderon R, Gonzalo-Garijo MA, Chaves A, de Argila D. Chelitis granulomatosa of Melkersson-Rosenthal syndrome: treatment with intralesional corticosteroid injections. Allergol Immunopathol 2004;32(1):36-8. PMID 14980194
- 66
- Rawlings NG, Valenzuela AA, Allen LH, Heathcote JG. Isolated eyelid edema in Melkersson-Rosenthal syndrome: a case series. Eye (Lond) 2012;26(1):163-6. PMID 22056858
- 67
- Rivera-Serrano CM, Man LX, Klein S, Schaitkin BM. Melkersson-Rosenthal syndrome: a facial nerve center perspective. J Plast Reconstr Aesthet Surg 2014;67(8):1050-4. PMID 24874612
- 68
- Rogers RS 3rd. Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol Clin 1996;14(2):371-9. PMID 8725591
- 69
- Rosenthal C. Klinisch-erbbiologischer Beit-rag zur Konstitutionspatholgie: Gemeinsamenmatous Aufreten von (rezidivierender familiarer) Facialislahmung, angioneurotischem Gesichtsodem und Lingua plicata in Arthritismus-Familien. Z Neurol Psychol 1931;131:475-501.
- 70
- Sachdeva S, Raina A, Sardana K, Malhotra P. A case of orofacial granulomatosis evolving into Melkersson Rosenthal syndrome in a child treated with a steroid free regimen of clofazimine and minocycline. Dermatol Ther 2021;34(4):e15009. PMID 34043275
- 71
- Saini AG, Sankhyan N, Padmanabh H, Das A, Singhi P. Recurrent facial palsy and electrophysiological findings in oligosymptomatic Melkersson-Rosenthal syndrome. Indian J Pediatr 2016;83(10):1188-90. PMID 27165478
- 72
- Santos S, Casadevall T, Pascual LF, et al. Neurological alterations related to Crohn's disease. Rev Neurol 2001;32(12):1158-62. PMID 11562848
- 73
- Scagliusi P, Sisto M, Lisi S, Lazzari A, D'Amore M. Hashimoto's thyroiditis in Melkersson-Rosenthal syndrome patient: casual association or related disease. Panminerva Med 2008;50(3):255-7. PMID 18927530
- 74
- Sciubba JJ, Said-Al-Naief N. Orofacial granulomatosis: presentation, pathology and management of 13 cases. J Oral Pathol Med 2003;32(10):576-85. PMID 14632932
- 75
- Shapiro M, Peters S, Spinelli HM. Melkersson-Rosenthal syndrome in the periocular area: a review of the literature and case report. Ann Plast Surg 2003;50(6):644-8. PMID 12783021
- 76
- Sopi Krasniqi M, Sllamniku Dalipi Z, Kastrati Dragidella D, Kondirolli L. Treatment of orofacial granulomatosis-9-month follow-up: a case report. Clin Med Insights Case Rep 2023;16:11795476231160046. PMID 36935761
- 77
- Stein J, Paulke A, Schacher B, Noehte M. An extraordinary form of the Melkersson-Rosenthal syndrome successfully treated with the tumour necrosisfactor-α blocker adalimumab. BMJ Case Rep 2014;2014. PMID 24827666
- 78
- Stein S, Mancini A. Melkersson-Rosenthal syndrome in childhood: successful management with combination steroid and minocycline therapy. J Am Acad Dermatol 1999;41(5 Pt 1):746-8. PMID 10534638
- 79
- Streeto JM, Watters FB. Melkersson’s syndrome. Multiple recurrence of Bell’s palsy and episodic facial edema. N Engl J Med 1964;271:308-9. PMID 14161770
- 80
- Sun B, Zhou C, Han Z. Facial palsy in Melkersson-Rosenthal syndrome and Bell's palsy: familial history and recurrence tendency. Ann Otol Rhinol Laryngol 2015;124(2):107-9. PMID 25124841
- 81
- Sutharaphan T, Chanprapaph K, Vachiramon V. Unsuccessful treatment of cheilitis granulomatosa with oral methotrexate. Case Rep Dermatol 2019;11(3):249-55. PMID 31616277
- 82
- Tan O, Atik B, Calka O. Plastic surgical solutions for Melkersson-Rosenthal syndrome: facial liposuction and cheiloplasty procedures. Ann Plast Surg 2006;56(3):268-73. PMID 16508356
- 83
- Tan Z, Zhang Y, Chen W, Gong W, Zhao J, Xu X. Recurrent facial palsy in Melkersson Rosenthal syndrome: total facial nerve decompression is effective to prevent further recurrence. Am J Otolaryngol 2015;36(3):334-7. PMID 25708818
- 84
- Tausch I, Sonnichsen N. Experiences with clofazimine therapy of Melkersson-Rosenthal syndrome. Hautarzt 1992;43(4):194-8. PMID 1597367
- 85
- Tonkovic-Capin V, Galbraith SS, Rogers RS 3rd, Binion DG, Yancey KB. Cutaneous Crohn’s disease mimicking Melkersson-Rosenthal syndrome: treatment with methotrexate. J Eur Acad Dermatol Venereol 2006;20(4):449-52. PMID 16643147
- 86
- Toumi A, Litaiem N, Gara S, Chabchoub I, et al. Chronic macrocheilia: a clinico-etiological series of 47 cases. Int J Dermatol 2021;60(12):1497-503. PMID 34081329
- 87
- Tummidi S, Nagendran P, Anthony ML, Ramani RJ, Shankaralingappa A, Gopinath H. Granulomatous cheilitis of Miescher: a rare entity. BMC Womens Health 2023;23(1):118. PMID 36944970
- 88
- van der Waal RI, Schulten EA, van de Scheur MR, Wauters IM, Starink TM, van der Waal I. Cheilitis granulomatosa. J Eur Acad Dermatol Venereol 2001;15(6):519-23. PMID 11843210
- 89
- van der Waal RI, Schulten EA, van der Meij EH, van de Scheur MR, Starink TM, van der Waal I. Cheilitis granulomatosa: overview of 13 patients with long-term follow-up--results of management. Int J Dermatol 2002;41(4):225-9. PMID 12066767
- 90
- Wadlington WB, Riley HD Jr, Lowbeer L. The Melkersson-Rosenthal syndrome. Pediatrics 1984;73(4):502-6. PMID 6709429
- 91
- Wang J, Li P, Jin X, Xu Y, Zhang X. Outcomes of recurrent facial palsy in Melkersson Rosenthal syndrome. Ann Otol Rhinol Laryngol 2015;124(3):232-4. PMID 25385841
- 92
- Wang S, Wang H, Shi X, et al. A case of Melkersson-Rosenthal syndrome with endocrine disorders: extraordinary efficiency of hydroxychloroquine and mechanism hypothesis. Eur J Neurol 2021;28(3):928-33. PMID 33270950
- 93
- Worsaae N, Christensen KC, Schiodt M, Reibel J. Melkersson-Rosenthal syndrome and cheilitis granulomatosa. A clinicopathologic study of thirty-three patients with special reference to their oral lesions. Oral Surg Oral Med Oral Pathol 1982;54(4):404-13. PMID 6959055
- 94
- Xu XG, Guan LP, Lv Y, et al. Exome sequencing identifies FATP1 mutation in Melkersson-Rosenthal syndrome. J Eur Acad Dermatol Venereol 2017;31(5):e230-2. PMID 27862329
- 95
- Yeatts RP, White WL. Granulomatous blepharitis as a sign of Melkersson-Rosenthal syndrome. Ophthalmology 1997;104(7):1185-9. PMID 9224474
- 96
- Yetiser S, Satar B, Kazkayasi M. Immunologic abnormalities and surgical experiences in recurrent facial nerve paralysis. Otol Neurotol 2002;23(5):772-8; discussion 778. PMID 12218633
- 97
- Zhang W, Yan Z. A case of complete Melkersson-Rosenthal syndrome: possibly associated with Mycolicibacterium fortuitum from odontogenic origin. J Dermatol 2023;50(7):935-7. PMID 36815397
- 98
- Zewde YZ. Melkersson-Rosenthal syndrome misdiagnosed as recurrent Bell's palsy: a case report and review of literature. Allergy Asthma Clin Immunol 2021;17(1):8. PMID 33422123
- 99
- Ziem PE, Pfrommer C, Goerdt S, Orfanos CE, Blume-Peytavi U. Melkersson-Rosenthal syndrome in childhood: a challenge in differential diagnosis and treatment. Br J Dermatol 2000;143(4):860-3. PMID 11069473
- 100
- Zimmer WM, Rogers RS 3rd, Reeve CM, Sheridan PJ. Orofacial manifestations of Melkersson-Rosenthal syndrome. A study of 42 patients and review of 220 cases from the literature. Oral Surg Oral Med Oral Pathol 1992;74(5):610-9. PMID 1437063
Contributors
All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.
Author
-
Douglas J Lanska MD MS MSPH
Dr. Lanska of the University of Wisconsin School of Medicine and Public Health and the Medical College of Wisconsin has no relevant financial relationships to disclose.
See Profile
Former Authors
- Lawrence Y Kim MD
- Lawrence Y Kim MD
Patient Profile
- Age range of presentation
-
- 2 to 65+ years
- Sex preponderance
-
- female>male, >1:1
- Heredity
-
- heredity may be a factor
- Population groups selectively affected
-
- none
- Occupation groups selectively affected
-
- none
ICD & OMIM codes
- ICD-10
-
- Melkersson syndrome: G51.2
- ICD-11
-
- Other specified disorders of facial nerve: 8B88.Y
This is an article preview.
Start a Free Account
to access the full version.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Questions or Comment?
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Also in This Category
-
-
Neuro-Oncology
NF2-related schwannomatosis
Dec. 13, 2024
-
Peripheral Neuropathies
Familial dysautonomia
Dec. 10, 2024
-
Neuromuscular Disorders
Neurogenetics and genetic and genomic testing
Dec. 09, 2024
-
General Neurology
Acute traumatic spinal cord injury
Dec. 09, 2024
-
Neuro-Oncology
Tumors of the skull base
Dec. 05, 2024
-
Peripheral Neuropathies
Peripheral nerve complications of HIV-1 infection
Nov. 25, 2024
-
Neuro-Ophthalmology & Neuro-Otology
Toxic and nutritional deficiency optic neuropathies
Nov. 24, 2024